Skip to main content

About
Awards
Events
Value Assessment
News
Donate
Blog
Apply

Improving public health by proactively investing in innovative research, education and value-driven health care

Home > Research > GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity

GUCY2C Opposes Systemic Genotoxic Tumorigenesis by Regulating AKT-Dependent Intestinal Barrier Integrity

Meet Our Awardees
Sitemap
Contact Us
PhRMA

PhRMA Foundation

950 F Street, N.W.
Suite 300
Washington, DC 20004
(202) 572-7756